Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ccd.31236 | DOI Listing |
Catheter Cardiovasc Interv
November 2024
Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Catheter Cardiovasc Interv
August 2024
Department of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Messina, Italy.
Background: The treatment of resistant coronary lesions (RCL) is a great challenge for interventional cardiologists. The excimer laser coronary atherectomy (ELCA) is a plaque modification tool based on a main mechanism of photomechanical effect leading to mechanical disruption of the plaque. Contrast dye injection during laser delivery has demonstrated to enhance its power.
View Article and Find Full Text PDFAsiaIntervention
March 2022
Cardiology Department, The Prince of Wales Hospital, Sydney, Australia.
Aims: Undilatable stents with severe peri-stent calcification are an important cause of target lesion failure and therapeutic options are limited. We report our initial experience with the safety and efficacy of excimer laser coronary atherectomy (ELCA)-assisted expansion of undilatable stents.
Methods And Results: ELCA was performed with saline, blood and contrast-enhanced trains.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!